Investigator
Lilei Zhang
BAYLOR COLLEGE OF MEDICINE · funded by NHLBI
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $1.4M
- First award
- Apr 1, 2022
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Akeso68momentum
OncologyPhase IIListed · 9926.HK
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Broadly applicable high throughput variant interpretation and validation for MYH7
$712kJul 1, 2024NHLBIBAYLOR COLLEGE OF MEDICINENIH RePORTER · 11097358 (opens the source filing in a new tab)
- R01
Deciphering the role of a circadian lncRNA in cardiac remodeling
$686kApr 1, 2022NHLBIBAYLOR COLLEGE OF MEDICINENIH RePORTER · 11055423 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources